NGeneBio participated in the Korean Society of Diagnostic Genetics ELSI-Rare Disease Symposium held from November 9th to 10th, 2023.

During this symposium, NGeneBio highlighted its various precision diagnostic panels for cancer based on NGS technology and introduced the analysis software, NGeneAnalySys.

 NGeneBio received significant attention from experts in the field of molecular diagnostics for its genome analysis precision diagnostic solutions based on NGS.